Valutazioni economiche sull'impiego di un nuovo contraccettivo ormonale somministrato per via transdermica

Translated title of the contribution: Cost analysis of the use of a new transdermally administered hormonal contraceptive

Sergio Di Matteo, Edgardo Somigliana, Marta Vinci, Giorgio Lorenzo Colombo

Research output: Contribution to journalArticlepeer-review

Abstract

Background. Oral hormonal contraception (HC) is the most widespread and effective system of pregnancy prevention in all industrialized countries. The effectiveness of the method in real practice depends on the drug being taken correctly, which therefore means complying with the right dosage. Aims. This study aimed to assess the cost of preventing pregnancy and its complications with conventional hormonal contraception and with HC in the form of a recently introduced transdermal patch. A five-year projection model was set up for possible events (extrauterine pregnancy, voluntary and spontaneous abortion, and childbirth), and the economic impact of the two different contraceptive strategies on those events was assessed. Results. From a pharmacoeconomic point of view, the patch is a better choice than oral contraceptives, and the economic benefits in the youngest age groups (age

Translated title of the contributionCost analysis of the use of a new transdermally administered hormonal contraceptive
Original languageItalian
Pages (from-to)277-283
Number of pages7
JournalTrends in Medicine
Volume6
Issue number4
Publication statusPublished - Oct 2006

ASJC Scopus subject areas

  • Internal Medicine
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Cost analysis of the use of a new transdermally administered hormonal contraceptive'. Together they form a unique fingerprint.

Cite this